Search

Your search keyword '"Myositis, Inclusion Body epidemiology"' showing total 12 results

Search Constraints

Start Over You searched for: Descriptor "Myositis, Inclusion Body epidemiology" Remove constraint Descriptor: "Myositis, Inclusion Body epidemiology" Search Limiters Full Text Remove constraint Search Limiters: Full Text
12 results on '"Myositis, Inclusion Body epidemiology"'

Search Results

1. Occupational and Hobby Exposures Associated With Myositis Phenotypes in a National Myositis Patient Registry.

2. Cost of illness in inclusion body myositis: results from a cross-sectional study in Germany.

Catalog

Books, media, physical & digital resources

3. Survival and associated comorbidities in inclusion body myositis.

4. Association of Ultraviolet Radiation Exposure With Dermatomyositis in a National Myositis Patient Registry.

5. Multicenter registry on inflammatory myositis from the Rheumatology Society in Madrid, Spain: Descriptive Analysis.

6. Multicenter questionnaire survey for sporadic inclusion body myositis in Japan.

7. Clinicopathologic features of sporadic inclusion body myositis in China.

8. Demographic features of Japanese patients with sporadic inclusion body myositis: a single-center referral experience.

9. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities.

10. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).

11. Sporadic-inclusion body myositis (s-IBM) is not so prevalent in Istanbul/Turkey: a muscle biopsy based survey.

12. Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC.